Yungjin Pharm Co Ltd (003520) - Total Liabilities

Latest as of September 2025: ₩156.23 Billion KRW ≈ $105.88 Million USD

Based on the latest financial reports, Yungjin Pharm Co Ltd (003520) has total liabilities worth ₩156.23 Billion KRW (≈ $105.88 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Yungjin Pharm Co Ltd (003520) equity growth momentum to track the company's year-over-year net asset growth rate.

Yungjin Pharm Co Ltd - Total Liabilities Trend (2013–2024)

This chart illustrates how Yungjin Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Yungjin Pharm Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Yungjin Pharm Co Ltd Competitors by Total Liabilities

The table below lists competitors of Yungjin Pharm Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Gabelli Healthcare & WellnessRx Trust NYSE:GRX	USA	$33.80 Million
Genic Co. Ltd KQ:123330	Korea	₩22.34 Billion
Kss Line KO:044450	Korea	₩1.49 Trillion
Smith-Midland Corp NASDAQ:SMID	USA	$33.42 Million
UPDATER SERVICES LIMITED NSE:UDS	India	Rs5.84 Billion
Donpon Precision TWO:3290	Taiwan	NT$2.37 Billion
AGV Products Corp TW:1217	Taiwan	NT$7.35 Billion
Samjin Pharm KO:005500	Korea	₩184.63 Billion

Liability Composition Analysis (2013–2024)

This chart breaks down Yungjin Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 003520 market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.20	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.74	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.63	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Yungjin Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Yungjin Pharm Co Ltd (2013–2024)

The table below shows the annual total liabilities of Yungjin Pharm Co Ltd from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩144.45 Billion ≈ $97.89 Million	+5.47%
2023-12-31	₩136.97 Billion ≈ $92.82 Million	+20.98%
2022-12-31	₩113.21 Billion ≈ $76.72 Million	+26.91%
2021-12-31	₩89.21 Billion ≈ $60.46 Million	+21.10%
2020-12-31	₩73.67 Billion ≈ $49.92 Million	-13.02%
2019-12-31	₩84.69 Billion ≈ $57.40 Million	+0.22%
2018-12-31	₩84.51 Billion ≈ $57.27 Million	+0.37%
2017-12-31	₩84.20 Billion ≈ $57.06 Million	-9.65%
2016-12-31	₩93.19 Billion ≈ $63.15 Million	-0.09%
2015-12-31	₩93.27 Billion ≈ $63.21 Million	+19.30%
2014-12-31	₩78.18 Billion ≈ $52.98 Million	+16.88%
2013-12-31	₩66.89 Billion ≈ $45.33 Million	--

About Yungjin Pharm Co Ltd

KO:003520 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$152.08 Million

₩224.41 Billion KRW

Market Cap Rank

#17619 Global

#722 in Korea

Share Price

₩1227.00

Change (1 day)

+0.57%

52-Week Range

₩1105.00 - ₩2170.00

All Time High

₩17500.00